"10.1371_journal.pone.0140358","plos one","2015-10-12T00:00:00Z","Alexandra Mangili; Julian Falutz; Jean-Claude Mamputu; Miganush Stepanians; Brooke Hayward","EMD Serono, Inc., Rockland, Massachusetts, United States of America; HIV Metabolic Unit, McGill University Health Centre, Montreal, Quebec, Canada; Theratechnologies Inc., Montreal, Quebec, Canada; PROMETRIKA, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: AM JF JCM MS BH. Performed the experiments: MS BH. Analyzed the data: AM JF JCM MS BH. Contributed reagents/materials/analysis tools: MS BH. Wrote the paper: AM JF JCM MS BH.","The authors have the following interests. Theratechnologies, Inc. sponsored the two Phase 3 studies. Exploratory analyses were sponsored and conducted by EMD Serono, Inc. Alexandra Mangili and Brooke Hayward are employed by EMD Serono, Inc., Jean-Claude Mamputu by Theratechnologies Inc. and Miganush Stepanians by PROMETRIKA. Jean-Claude Mamputu has stock/share options in Theratechnologies, Inc. Miganush Stepanians has received fees from EMD Serono, Inc for statistical analysis, and as an employee of PROMETRIKA provides statistical analysis support to EMD Serono, Inc from time to time on a consultancy basis. Julian Falutz has received fees for consultancy from Theratechnologies, Inc and travel/accommodation/meeting expenses from Abbott, Canada, and has received payment for lectures including service on speakers bureaus from Serono, USA, and ViiV, Canada. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","10","Alexandra Mangili","AM",5,TRUE,5,2,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
